Synergistic effects of concurrent blockade of PI3K and MEK pathways in pancreatic cancer preclinical models

Authors

Hua Zhong, Washington University School of Medicine in St. Louis
Cesar Sanchez, Pontificia Universidad Catolica de Chile
Dirk Spitrzer, Washington University School of Medicine in St. Louis
Stacy Plambeck-Suess, Washington University School of Medicine in St. Louis
Jesse Gibbs, Washington University School of Medicine in St. Louis
William G. Hawkins, Washington University School of Medicine in St. LouisFollow
David Denardo, Washington University School of Medicine in St. Louis
Feng Gao, Washington University School of Medicine in St. Louis
Robert A. Pufahl, Washington University School of Medicine in St. Louis
Albert C. Lockhart, Washington University School of Medicine in St. LouisFollow
Mai Xu, Washington University School of Medicine in St. Louis
David Linehan, Washington University School of Medicine in St. Louis
Jason Weber, Washington University School of Medicine in St. Louis
Andrea Wang-Gillam, Washington University School of Medicine in St. Louis

Journal

PLoS One

Publication Date

2013

Volume

8

Issue

10

Inclusive Pages

e77243

Document Type

Open Access Publication

DOI

10.1371/journal.pone.0077243

Rights and Permissions

Zhong H, Sanchez C, Spitrzer D, Plambeck-Suess S, Gibbs J, et al. (2013) Synergistic Effects of Concurrent Blockade of PI3K and MEK Pathways in Pancreatic Cancer Preclinical Models. PLoS ONE 8(10): e77243. doi:10.1371/journal.pone.0077243

Recommended Citation

Zhong, Hua; Sanchez, Cesar; Spitrzer, Dirk; Plambeck-Suess, Stacy; Gibbs, Jesse; Hawkins, William G.; Denardo, David; Gao, Feng; Pufahl, Robert A.; Lockhart, Albert C.; Xu, Mai; Linehan, David; Weber, Jason; and Wang-Gillam, Andrea, "Synergistic effects of concurrent blockade of PI3K and MEK pathways in pancreatic cancer preclinical models." PLoS One. 8, 10. e77243. (2013).
https://digitalcommons.wustl.edu/open_access_pubs/1988